Nancy Whiting on LinkedIn: Recludix Pharma Enters into a Strategic Collaboration with Sanofi to… | 20 comments
![Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care](https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-press-release-collaboration-announcement-sanofi.png)
Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care
Sanofi on LinkedIn: We aim to be an industry-leading company in Immunology. We are announcing… | 17 comments
Sanofi on LinkedIn: Press Release: Sanofi announces agreement for potential first-in-class… | 26 comments
![Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care | BioSpace Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care | BioSpace](https://mms.businesswire.com/media/20230501005091/en/1778081/4/Press-Featured-Image-SanofixFlatiron.jpg)
Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care | BioSpace
![SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate](https://mma.prnewswire.com/media/2144614/Jaeyong_Ahn_CEO_of_SK_bioscience__left__Thomas_Triomphe_Head_of_Vaccines_GBU_at_Sanofi__right.jpg?p=facebook)
SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate
![Logo of Pharmaceutical French group Sanofi-Aventis during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on February 24, 2006. Photo Logo of Pharmaceutical French group Sanofi-Aventis during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on February 24, 2006. Photo](https://c8.alamy.com/comp/2E95XFE/logo-of-pharmaceutical-french-group-sanofi-aventis-during-a-press-conference-to-present-the-full-year-2005-results-sanofi-aventis-announced-a-serie-of-positive-drug-research-developments-in-paris-on-february-24-2006-photo-by-christophe-guibbaudabacapresscom-2E95XFE.jpg)
Logo of Pharmaceutical French group Sanofi-Aventis during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on February 24, 2006. Photo
![Paul Hudson, Chief Executive Officer of Sanofi speaks to the press at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, on June 16, 2020. The visit comes Paul Hudson, Chief Executive Officer of Sanofi speaks to the press at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, on June 16, 2020. The visit comes](https://c8.alamy.com/comp/2DFAY2T/paul-hudson-chief-executive-officer-of-sanofi-speaks-to-the-press-at-french-drugmakers-vaccine-unit-sanofi-pasteur-plant-in-marcy-letoile-near-lyon-central-france-on-june-16-2020-the-visit-comes-after-rival-pharmaceutical-company-this-weekend-announced-a-deal-to-supply-400-million-vaccine-doses-to-eu-countries-including-france-photo-by-bonypoolabacapresscom-2DFAY2T.jpg)
Paul Hudson, Chief Executive Officer of Sanofi speaks to the press at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, on June 16, 2020. The visit comes
Press Release: Sanofi unveils new corporate brand and logo – unites the company under one purpose and a single identity
![Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery – Atomwise Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery – Atomwise](https://www.atomwise.com/wp-content/uploads/2022/08/atomwise-signs-strategic-collaboration-sanofi-pr-1200x630-1.png)
Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery – Atomwise
![Sanofi в X: „Press release: #Sanofi announces that it will acquire @ProteinSciences https://t.co/Uvipij6Bkr https://t.co/FoBXWy5xe4“ / X Sanofi в X: „Press release: #Sanofi announces that it will acquire @ProteinSciences https://t.co/Uvipij6Bkr https://t.co/FoBXWy5xe4“ / X](https://pbs.twimg.com/media/DEhiniWXcAIbYeM.jpg)